Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 9601-9650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06887816
Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
N/ARecruiting
70 participants
Started: Mar 12, 2025 · Completed: Mar 31, 2029
1 condition1 sponsor2 locations
NCT06990373
Iron Status of Non-anemic Pregnant Women in First Trimester
N/ARecruiting
600 participants
Started: Mar 12, 2025 · Completed: Aug 30, 2025
3 conditions1 sponsor1 location
NCT07040449
Stress Trajectories and Anhedonia in Adolescence Research Study
NARecruiting
192 participants
Started: Mar 12, 2025 · Completed: Feb 28, 2030
3 conditions2 sponsors1 location
NCT05720299
A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.
NARecruiting
90 participants
Started: Mar 12, 2025 · Completed: Feb 10, 2026
1 condition1 sponsor1 location
NCT06870058
A Study of NH280105 in Healthy Adult Participants
PHASE1Recruiting
48 participants
Started: Mar 12, 2025 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06891365
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
PHASE1Recruiting
48 participants
Started: Mar 12, 2025 · Completed: Jan 25, 2027
2 conditions1 sponsor1 location
NCT06716086
A Novel Shape Memory Alloy-Based Orthosis for Proximal Interphalangeal Joint Stiffness
NARecruiting
90 participants
Started: Mar 12, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06854445
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
PHASE2Recruiting
55 participants
Started: Mar 12, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor24 locations
NCT06953921
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
N/ARecruiting
100 participants
Started: Mar 12, 2025 · Completed: Sep 12, 2025
1 condition1 sponsor1 location
NCT06893614
Facial Conformation Meshes for Orthognathic Surgery
N/ARecruiting
13 participants
Started: Mar 12, 2025 · Completed: May 1, 2025
1 condition4 sponsors2 locations
NCT06551272
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
PHASE2Recruiting
34 participants
Started: Mar 12, 2025 · Completed: Dec 12, 2026
1 condition1 sponsor6 locations
NCT06714279
Laparoscopic-Assisted Transversus Abdominus Plane Block Versus Intraperitoneal Irrigation of Local Anesthetic for Patients Undergoing Laparoscopic Cholecystectomy
PHASE1Recruiting
144 participants
Started: Mar 12, 2025 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06898073
Dual-task Training During Curved Walking in Stroke Patients
NARecruiting
60 participants
Started: Mar 12, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06765590
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
NARecruiting
24 participants
Started: Mar 12, 2025 · Completed: Feb 24, 2026
1 condition6 sponsors1 location
NCT06662058
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
NARecruiting
118 participants
Started: Mar 12, 2025 · Completed: Oct 31, 2029
33 conditions3 sponsors1 location
NCT06915246
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
PHASE2Recruiting
49 participants
Started: Mar 12, 2025 · Completed: Apr 30, 2026
3 conditions1 sponsor4 locations
NCT06998394
A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer
PHASE2Recruiting
30 participants
Started: Mar 12, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06792695
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
PHASE2Recruiting
120 participants
Started: Mar 12, 2025 · Completed: Jun 7, 2028
1 condition2 sponsors76 locations
NCT06453486
A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
PHASE2Recruiting
43 participants
Started: Mar 12, 2025 · Completed: Apr 30, 2030
1 condition1 sponsor1 location
NCT06940843
A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program
NARecruiting
60 participants
Started: Mar 12, 2025 · Completed: Jul 31, 2028
2 conditions2 sponsors2 locations
NCT06476132
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
PHASE2Recruiting
234 participants
Started: Mar 12, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor8 locations
NCT06688331
Treatment of Pre-diabetic State in Pediatric Population With Treg Cell Preparations and Rituximab
PHASE2Recruiting
150 participants
Started: Mar 12, 2025 · Completed: Dec 31, 2032
3 conditions4 sponsors8 locations
NCT06869889
Analgesia Following Lumbar Discectomy
NARecruiting
120 participants
Started: Mar 12, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06907810
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
NARecruiting
300 participants
Started: Mar 12, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT07002762
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NARecruiting
100 participants
Started: Mar 12, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06839144
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
PHASE2Recruiting
60 participants
Started: Mar 12, 2025 · Completed: Aug 31, 2026
2 conditions3 sponsors2 locations
NCT06874192
Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
PHASE1Recruiting
30 participants
Started: Mar 12, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT06785818
Long-term Follow up Local Registry Study of Kymriah in South Korea
N/ARecruiting
500 participants
Started: Mar 12, 2025 · Completed: Dec 30, 2039
1 condition1 sponsor8 locations
NCT06582212
Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
NARecruiting
100 participants
Started: Mar 12, 2025 · Completed: Sep 12, 2027
5 conditions1 sponsor4 locations
NCT06815484
Preventing Burnout Among Caregivers Through Physical Activity
NARecruiting
86 participants
Started: Mar 12, 2025 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06714357
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
PHASE2Recruiting
130 participants
Started: Mar 12, 2025 · Completed: Jun 20, 2027
1 condition1 sponsor5 locations
NCT06902311
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
PHASE2Recruiting
90 participants
Started: Mar 12, 2025 · Completed: Feb 29, 2028
4 conditions1 sponsor1 location
NCT06526585
Stress Management Program
NARecruiting
80 participants
Started: Mar 12, 2025 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06560905
Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
PHASE2Recruiting
16 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06961123
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
N/ARecruiting
600 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06840470
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
PHASE4Recruiting
40 participants
Started: Mar 11, 2025 · Completed: Sep 11, 2027
1 condition1 sponsor1 location
NCT06575686
Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
PHASE2Recruiting
33 participants
Started: Mar 11, 2025 · Completed: Jul 16, 2028
6 conditions2 sponsors2 locations
NCT06673329
Brodalumab in the Treatment of Immune-Related Adverse Events
PHASE1Recruiting
11 participants
Started: Mar 11, 2025 · Completed: Nov 30, 2026
18 conditions2 sponsors1 location
NCT07089511
Cord Blood Platelet Poor Plasma Eye Drops
NARecruiting
100 participants
Started: Mar 11, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06830980
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
NARecruiting
30 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06738771
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
N/ARecruiting
600 participants
Started: Mar 11, 2025 · Completed: Jan 31, 2027
6 conditions1 sponsor48 locations
NCT06773910
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
PHASE2Recruiting
250 participants
Started: Mar 11, 2025 · Completed: Sep 30, 2032
1 condition2 sponsors23 locations
NCT06559332
Coronary Artery Disease Assessment Strategies in TAVI Patients
NARecruiting
546 participants
Started: Mar 11, 2025 · Completed: Mar 31, 2032
3 conditions3 sponsors1 location
NCT05973864
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
PHASE2Recruiting
220 participants
Started: Mar 11, 2025 · Completed: Aug 31, 2028
1 condition1 sponsor8 locations
NCT06972264
Safety and Efficacy of VDPHL01 in Males With AGA
PHASE3Recruiting
480 participants
Started: Mar 11, 2025 · Completed: Nov 30, 2026
3 conditions1 sponsor41 locations
NCT06551038
Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
NARecruiting
240 participants
Started: Mar 11, 2025 · Completed: Sep 30, 2028
1 condition1 sponsor10 locations
NCT06977113
Maternal High Fibre Fermented Diet Effect on Breastfed Infant Gut Microbiome
NARecruiting
56 participants
Started: Mar 11, 2025 · Completed: May 31, 2028
2 conditions1 sponsor1 location
NCT06911333
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 11, 2025 · Completed: Feb 20, 2030
7 conditions1 sponsor3 locations
NCT06770673
Together Overcoming Diabetes - Great Plains
NARecruiting
80 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT07022223
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
PHASE2Recruiting
51 participants
Started: Mar 11, 2025 · Completed: Sep 11, 2029
1 condition18 sponsors18 locations